Literature DB >> 4878637

Clinical trial of protamine in the treatment of malignant diseases.

J E Wright.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4878637      PMCID: PMC2008396          DOI: 10.1038/bjc.1968.49

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  EFFECT OF PROTAMINE SULPHATE ON EXPERIMENTAL TUMOURS IN MICE.

Authors:  P W MUGGLETON; J G MACLAREN; W J DYKE
Journal:  Lancet       Date:  1964-02-22       Impact factor: 79.321

2.  PROTAMINE DERIVATIVES IN TREATMENT OF ADVANCED CARCINOMA OF THE BREAST.

Authors:  R A O'MEARA; M J O'HALLORAN
Journal:  Lancet       Date:  1963-09-21       Impact factor: 79.321

3.  The cytopathic effect of fibrinolytic agents and human placental fractions on HeLa cells.

Authors:  R D THORNES; W T MARTIN
Journal:  Ir J Med Sci       Date:  1961-11       Impact factor: 1.568

4.  Some properties of the cancer coagulative factor.

Authors:  R A O'MEARA; R D THORNES
Journal:  Ir J Med Sci       Date:  1961-03       Impact factor: 1.568

5.  A method of detecting and estimating inhibitors of the cancer coagulative factor.

Authors:  R D THORNES; R A O'MEARA
Journal:  Ir J Med Sci       Date:  1961-08       Impact factor: 1.568

  5 in total
  1 in total

1.  Enhancement of anti-tumour effect by cooling.

Authors:  J P Austin; E M Glaser
Journal:  Int J Biometeorol       Date:  1969-10       Impact factor: 3.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.